Article Information
- Received April 28, 2004
- Revision received June 14, 2004
- Accepted June 16, 2004
- First published July 28, 2004.
- Version of record published July 28, 2004.
Author Information
- Ellen K. Wittmack1,3,4,
- Anthony M. Rush2,3,4,
- Matthew J. Craner2,3,4,
- Mitchell Goldfarb5,
- Stephen G. Waxman2,3,4, and
- Sulayman D. Dib-Hajj2,3,4
- Departments of 1Pharmacology and 2Neurology and 3The Center for Neuroscience and Regeneration Research, Yale University School of Medicine, New Haven, Connecticut 06510, 4Rehabilitation Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, and 5Department of Biological Sciences, Hunter College of City University, New York, New York 10021
Author contributions
Disclosures
- Received April 28, 2004.
- Revision received June 14, 2004.
- Accepted June 16, 2004.
This work was supported in part by grants from the National Multiple Sclerosis Society and the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs. The Center for Neuroscience and Regeneration Research is a collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University. E.K.W. was supported by a National Research Service Award predoctoral fellowship from the National Institute of Neurological Disorders and Stroke. We thank Dr. Joel Black for valuable discussions.
Correspondence should be addressed to Dr. Sulayman D. Dib-Hajj, The Center for Neuroscience and Regeneration Research, Veterans Affairs Connecticut Healthcare System, 950 Campbell Avenue, 127A, Building 34, West Haven, CT 06516. E-mail: sulayman.dib-hajj{at}yale.edu.
Copyright © 2004 Society for Neuroscience 0270-6474/04/246765-11$15.00/0
Online Impact